ID Biomedical Corp.

Vancouver, BC, Canada; acquired the vaccines business of Shire Pharmaceuticals in Sept. 2004; merged into GlaxoSmithKline plc in late 2005; influenza vaccine manufacturing facility in Sainte-Foy, Laval, Quebec, Canada